Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a fully-integrated biopharmaceutical company with marketed products and a ...

China continues to boost pharmaceutical innovation through regulatory reforms and as a result, "the pace of new drug ...

In pharma, buying software (instead of building) means working with industry professionals who can develop solutions to meet ...

Yunu, creator of the industry’s first end-to-end clinical trial imaging workflow platform supporting sites, CROs and pharma, ...

End-to-end automation could offer significant benefits: speed, accuracy, and scalability. Digital workers perform repetitive ...

Projected return on investment in pharma research and development (R&D) in 2024 has risen to 5.9%, continuing the upward ...

Cancer remains one of the leading causes of death worldwide, with millions of new cases diagnosed each year. Advances in ...

NorthWest EHealth is a winner in the Innovation, Safety, and Diversity categories in the 2025 Pharmaceutical Excellence ...

The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. | The ...

The event "Healthcare Shift" was held today in Rome at the American Studies Center. Among the topics discussed were the ...

Deloitte, in a series of annual reports on "Measuring the return from pharmaceutical innovation," in collaboration with other member firms, has provided insights into the state of biopharma R&D ...